Zurück zu Ihrem Suchergebnis

Beschreibung

Anti-Muellerian hormone type-2 receptor (EC 2.7.11.30, UniProt Q16671, also known as Anti-Muellerian hormone type II receptor, AMH type II receptor, MIS type II receptor, MISRII, MRII) is encoded by the AMHR2 (also known as AMHR, MISR2) gene (Gene ID 269) in human. Anti-Muellerian hormone (AMH) or Muellerian inhibiting substance (MIS) is a TGF- family homodimeric glycoprotein hormone. AMH/MIS is responsible for regression of the Muellerian ducts in male embryos, it is also produced in both male and female gonads after birth and plays a role in folliculogenesis, germ cell maturation and gonadal function. AMH/MIS interacts with single membrane-spanning serine/threonine kinase receptors type I (AMHR1/MISRI) and II (AMHR2/MISRII). AMHR1 is nearly ubiquitously expressed, whereas AMHR2 is mainly detected in the gonads and other organs of the reproductive tract. AMHR2 is found expressed in the majority of human granulosa cell tumors (GCTs) and epithelial ovarian cancers (EOCs). In addition, AMHR2 expression is also reported in breast and prostate cancers. Human AMHR2 is produced with a signal peptide (a.a. 1-17), which is removed posttranslationally to yield the mature receptor with an N-terminal extracellular region (a.a. 18-149), a singl-transmembrane domain (a.a. 150-170), and a large cytoplasmic region (a.a. 171-573) that contains the kinase domain (a.a. 203-518, a.a. 230 ATP-binding site, a.a. 333 proton acceptor site, a.a. 209-217 ATP-binding site).